Pennant Investors, LP Bellerophon Therapeutics, Inc. Transaction History

Pennant Investors, LP

  • $367 Million
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020
SELL
$9.43 - $20.28 $661,344 - $1.42 Million
-70,132 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$3.39 - $18.0 $237,747 - $1.26 Million
70,132 New
70,132 $769,000

Others Institutions Holding BLPH

# of Institutions
1
Shares Held
44K
Call Options Held
0
Put Options Held
0
View Full List

About Bellerophon Therapeutics, Inc.

BLPH Quotes by TradingView
  • Ticker BLPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,545,450
  • Market Cap $382K
  • Description
  • Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development...
More about BLPH
Track This Portfolio

Track Pennant Investors, LP Portfolio

Follow Pennant Investors, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pennant Investors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pennant Investors, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email